Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin

Biochemical and Biophysical Research Communications

Volumn 353, Issue 2, 2007, Pages 351-356

  Harada, Kazutsune ^a   Okiyoneda, Tsukasa ^a   Hashimoto, Yasuaki ^a   Oyokawa, Kimiko ^a   Nakamura, Kimitoshi ^a   Suico, Mary Ann ^a   Shuto, Tsuyoshi ^a   Kai, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

F508 CFTR; Calreticulin; CFTR; Curcumin

Indexed keywords

CALRETICULIN; CURCUMIN; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; INCUBATION TIME; LOW TEMPERATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TEMPERATURE SENSITIVITY; WILD TYPE;

ANIMALS; CALRETICULIN; CHO CELLS; CRICETINAE; CRICETULUS; CURCUMIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOWN-REGULATION; ENDOPLASMIC RETICULUM; URACIL;

CRICETULUS GRISEUS;

EID: 33845802655     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.036     Document Type: Article

References (29)

1. Gadsby D.C., Vergani P., and Csanady L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440 (2006) 477-483
2. Rommens J.M., Iannuzzi M.C., Kerem B., Drumm M.L., Melmer G., Dean M., Rozmahel R., Cole J.L., Kennedy D., Hidaka N., et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (1989) 1059-1065
3. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
4. Du K., Sharma M., and Lukacs G.L. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat. Struct. Mol. Biol. 12 (2005) 17-25
5. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., and Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358 (1992) 761-764
6. Li C., Ramjeesingh M., Reyes E., Jensen T., Chang X., Rommens J.M., and Bear C.E. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat. Genet. 3 (1993) 311-316
7. Egan M.E., Pearson M., Weiner S.A., Rajendran V., Rubin D., Glockner-Pagel J., Canny S., Du K., Lukacs G.L., and Caplan M.J. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304 (2004) 600-602
8. - channel activity. J. Biol. Chem. 280 (2005) 5221-5226
9. Wang W., Li G., Clancy J.P., and Kirk K.L. Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs. J. Biol. Chem. 280 (2005) 23622-23630
10. Lipecka J., Norez C., Bensalem N., Baudouin-Legros M., Planelles G., Becq F., Edelman A., and Davezac N. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J. Pharmacol. Exp. Ther. 317 (2006) 500-505
11. Dragomir A., Bjorstad J., Hjelte L., and Roomans G.M. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 322 (2004) 447-451
12. Loo T.W., Bartlett M.C., and Clarke D.M. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem. Biophys. Res. Commun. 325 (2004) 580-585
13. Song Y., Sonawane N.D., Salinas D., Qian L., Pedemonte N., Galietta L.J., and Verkman A.S. Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J. Biol. Chem. 279 (2004) 40629-40633
14. Grubb B.R., Gabriel S.E., Mengos A., Gentzsch M., Randell S.H., Van Heeckeren A.M., Knowles M.R., Drumm M.L., Riordan J.R., and Boucher R.C. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34 (2006) 355-363
15. Amaral M.D. Processing of CFTR: traversing the cellular maze-how much CFTR needs to go through to avoid cystic fibrosis?. Pediatr. Pulmonol. 39 (2005) 479-491
16. Harada K., Okiyoneda T., Hashimoto Y., Ueno K., Nakamura K., Yamahira K., Sugahara T., Shuto T., Wada I., Suico M.A., and Kai H. Calreticulin negatively regulates the cell surface expression of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 281 (2006) 12841-12848
17. Okiyoneda T., Harada K., Takeya M., Yamahira K., Wada I., Shuto T., Suico M.A., Hashimoto Y., and Kai H. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol. Biol. Cell 15 (2004) 563-574
18. Suico M.A., Yoshida H., Seki Y., Uchikawa T., Lu Z., Shuto T., Matsuzaki K., Nakao M., Li J.D., and Kai H. Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein. J. Biol. Chem. 279 (2004) 19091-19098
19. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
20. Okiyoneda T., Wada I., Jono H., Shuto T., Yoshitake K., Nakano N., Nagayama S., Harada K., Isohama Y., Miyata T., and Kai H. Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator. FEBS Lett. 526 (2002) 87-92
21. Egan M.E., Glockner-Pagel J., Ambrose C., Cahill P.A., Pappoe L., Balamuth N., Cho E., Canny S., Wagner C.A., Geibel J., and Caplan M.J. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8 (2002) 485-492
22. Waser M., Mesaeli N., Spencer C., and Michalak M. Regulation of calreticulin gene expression by calcium. J. Cell Biol. 138 (1997) 547-557
23. Bierhaus A., Zhang Y., Quehenberger P., Luther T., Haase M., Muller M., Mackman N., Ziegler R., and Nawroth P.P. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb. Haemost. 77 (1997) 772-782
24. Davis P.B., and Drumm M.L. Some like it hot: curcumin and CFTR. Trends Mol. Med. 10 (2004) 473-475
25. Huang T.S., Kuo M.L., Lin J.K., and Hsieh J.S. A labile hyperphosphorylated c-Fos protein is induced in mouse fibroblast cells treated with a combination of phorbol ester and anti-tumor promoter curcumin. Cancer Lett. 96 (1995) 1-7
26. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
27. 2+. J. Biol. Chem. 276 (2001) 46905-46911
28. Gentzsch M., Chang X.B., Cui L., Wu Y., Ozols V.V., Choudhury A., Pagano R.E., and Riordan J.R. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15 (2004) 2684-2696
29. Heda G.D., Tanwani M., and Marino C.R. The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells. Am. J. Physiol. Cell. Physiol. 280 (2001) C166-C174